$AME

Citigroup Adjusts Price Target on AMETEK to $263 From $261

Citigroup raised its price target for AMETEK (AME) from $261 to $263. The stock is currently trading at $248.58, up 0.43% on the day but down 1.33% over the past year. Morgan Stanley also recently increased its target to $275 from $245.

Original reporting
Published Oct 12, 2026, 9:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 9:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

Analyst upgrades can prompt short‑term buying, but the modest size suggests limited price movement.

02

Market read

Primary relevance is to AMETEK (ticker AME); broader market impact is minimal.

03

What to watch

No new earnings or operational data accompany the target change, limiting its material impact.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

The article reports recent analyst price‑target adjustments for AMETEK, with Citigroup moving its target slightly higher and Morgan Stanley having made a prior adjustment.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

Citigroup raised AMETEK's price target to $263 from $261, indicating a modest bullish view.

Expected impact

modest upside pressure as the market prices in the higher target

Evidence & confidence

Price‑target upgrades are a direct catalyst that can attract buying interest, though the change is small.

Market effects

Small positive signal for industrial equipment sector, but limited spillover.

US market focus; no broader regional effect.

Low; relevance confined to AMETEK and its immediate peers.

Counterpoint

The target raise is marginal and may already be priced in; investors could wait for larger catalysts.

Key entities

  • Citigroup

    Raised AMETEK price target to $263.

  • Morgan Stanley

    Previously raised AMETEK price target to $275 from $245.

Related articles

$AMEMedAI 9/10

AMETEK’s (AME) $5B Deal Bets Big On A Hot Streak

AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.

$RIMEMed

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75

Carets Corp is exploring a potential sale, including its technology and patents. Algorhythm Holdings (RIME) and Biomerica (BMRA) are evaluating strategic alternatives. nVent Electric (NVT) acquired Maverick Power for $1.75B, with up to $550M more in performance-based payments. Descartes (DSGX) bought Tai for $100M, and Navitas (NVTS) acquired Claros for up to $232.8M. Booz Allen (BAH) completed a $720M acquisition, and Elastic (ESTC) acquired Deductive AI. BioXcel (BTAI) filed for Chapter 11 ban

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.